Martin Landray
MartinLandray
More results from the RECOVERY trial - Hydroxychloroquine:Among patients hospitalised with COVID-19, hydroxychloroquine (HCQ) did not improve 28-day mortality, duration of hospital stay, or risk of progressing to invasive mechanical
Read more
Latest paper from RECOVERY trial:In patients admitted to hospital with COVID-19, lopinavir–ritonavir did not reduce 28-day mortality, duration of hospital stay, or risk of progressing to invasive mechanical ventilation or
Read more